Global Angiogenesis Assay Market Size, Status and Forecast 2021-2027

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.
Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.
North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.

Market Analysis and Insights: Global Angiogenesis Assay Market
The global Angiogenesis Assay market size is projected to reach US$ 28 million by 2027, from US$ 17 million in 2020, at a CAGR of 7.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Angiogenesis Assay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Angiogenesis Assay market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Angiogenesis Assay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Angiogenesis Assay market.

Global Angiogenesis Assay Scope and Market Size
Angiogenesis Assay market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiogenesis Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
In Vitro Assay Kit
In Vivo Assay Kit

Segment by Application
Academic Institution
Biotech Companies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abcam
Bio-Techne
Thermo Fisher Scientific
Cell Biolabs, Inc.
BioVision, Inc
PromoCell GmbH
Merck KGaA
Kollodis BioSciences
Sartorius (Essen BioScience)
Creative Bioarray

Frequently Asked Questions